Skip to main content
Equibles

Diego Miralles, M.D.

Artiva Biotherapeutics, Inc. (ARTV)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Diego Miralles, M.D.

Artiva Biotherapeutics, Inc. reported in an 8-K filed May 19, 2026 that Diego Miralles, M.D. was appointed President and Head of Research and Development, effective May 18, 2026. Artiva Biotherapeutics, Inc. reported in an 8-K filed May 19, 2026 that Diego Miralles, M.D. resigned as member of the Board of Directors, effective May 18, 2026. Artiva Biotherapeutics, Inc. reported in an 8-K filed January 29, 2025 that Diego Miralles, M.D. was appointed chair of the Clinical Strategy Committee, effective January 28, 2025.

“On the Effective Date, the Company appointed (i) Dr. Aslan as the Company's principal financial officer and principal accounting officer and (ii) Dr. Miralles as the Company's President and Head of Research and Development.”
Artiva Biotherapeutics, Inc. Form 8-K, filed May 19, 2026 · Read the filing
“On May 18, 2026, Diego Miralles, M.D. resigned as a member of the Board of Directors (the "Board") of Artiva Biotherapeutics, Inc. (the "Company"), effective May 18, 2026, in connection with his appointment as President and Head of Research and Development of the Company as described below.”
Artiva Biotherapeutics, Inc. Form 8-K, filed May 19, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Artiva Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.